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A 76-year-old female patient with a multiple medical history developed refractory pancytopenia during
treatment for peptic ulcer, bacteremia, pneumonia, and respiratory failure. Bone marrow biopsy revealed
hypocellularity with few hematopoietic cells, which was indicative of aplastic anemia. Common causes
including viral infection, mycobacterial infection, environmental exposure, congenital bone marrow
disorder, and hematologic malignancy were primarily excluded. Identical Serratia marcescens cultures
were isolated from the central venous catheter tip and bone marrow, and the pancytopenia improved
gradually with proper antibiotics treatment. This case indicates that nosocomial S. marcescens infection
may cause potentially fatal acquired aplastic anemia. Crucial issues in avoiding aplastic anemia include
confronting increasing mortality and morbidity caused by nosocomial infection, improving environ-
mental hygiene, early diagnosis of proper etiology, and adequate antibiotics treatment.
Copyright  2011, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Aplastic anemia is a syndrome of bone marrow failure charac-
terized by peripheral pancytopenia and marrow hypoplasia1,2. To
distinguish inherited and acquired aplastic anemia may present
a clinical challenge3. Untreated or improperly treated aplastic
anemia is an illness that leads to rapid death due to secondary
infection and massive bleeding. In addition, acquired aplastic
anemia may develop in patients exposed to chemical substances or
illicit drugs, or in those with viral infections or immunologic
disorders4e7. Nosocomial bacterial infection, such as extended-
spectrum b-lactamase-producing Serratia marcescens, may cause
disseminated infection, including bone marrow infection. In addi-
tion to ensuring proper antibiotic treatment, all medical staff
should be vigilant about environmental hygiene to avoid a further
outbreak of infection8e10. The case of an elderly woman in whom
acquired aplastic anemia induced by Serratia marcescens bone
marrow infection was diagnosed is presented. The patient was
cured of infection after a full course of antibiotic therapy.erest.
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A 76-year-old woman with a multiple medical history of type
2 diabetes mellitus, hypertension, cerebral infarction, bilateral
hydronephrosis with bilateral double-J insertion, congestive heart
failure, and gastric ulcer was bedridden after tracheostomy and also
had buttock pressure sores, old inferior wall myocardial infarction,
and neurogenic bladder after cystostomy. She had been admitted to
our hospital several times because of these conditions during the
past 9 years.
This time she was brought to our hospital because of tarry stools
and poor response to stimulation that had been noted by her
caregiver for 2 days. Esophageal ulcer, gastric ulcer, and gastro-
esophageal reﬂux disease were diagnosed by esophagogas-
troduodenoscopy examination. Initial laboratory data showed
leukocytosis with shift to left, hyponatremia, and hypocapnia.
Empiric antibiotic therapy with amoxicillin/clavulanate was ﬁrst
prescribed and then changed to cefoxitin because urine culture
showed infection with Klebsiella pneumoniae and Escherichia coli.
The presence of methicillin-resistant coagulase negative Staphylo-
coccus (MRCNS) by blood cultures, Candida tropicalis by pus culture
from pressure sore, and Acinetobacter baumannii and Pseudomonas
aeruginosa coinfection by sputum cultures was reported, which led
to a change in antibiotic regimen to teicoplanin for 14 days, oral
ﬂuconazole for 7 days, and imipenem for 10 days, respectively.
Progressing dyspnea and carbon dioxide retentionwere discoveredcy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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ventilation was provided for 7 days after the 28th day of admission.
Meanwhile, we observed a signiﬁcant decrease in hemoglobin
level from 10.5 g/dL to 7.6 g/dL, leukocyte counts from 10,900/mcL
to 2100/mcL, and platelet counts from 271,000/mcL to 36,000/mcL.
No abnormal cells such as myeloblasts or atypical lymphoid cells
were present. Blood loss from gastrointestinal tract was ﬁrst sus-
pected due to positive peptic ulcer disease and the strong presence
of occult blood in stool passage; therefore, omeprazole was given
intravenously, along with transfusion of blood products (packed
red blood cells and platelet). Sepsis-related leukocytopenia was not
likely because of the absence of fever or hypotension; therefore,
unnecessary medications including antibiotic therapy were dis-
continued except for teicoplanin for recurrent MRCNS bloodstream
infection. Due to refractory pancytopenia, biopsy of bone marrow
for suspicious hematopoietic stem cell dysfunction was obtained,
and samples were also collected for Gram stain, routine bacterial
culture, acid-fast smears and cultures, and fungus culture. The
central venous catheter was changed every 10 days, and we sent
the tip for culture routinely.
Histopathologically, the bone marrow showed marked hypo-
cellularity with less than 5% hematopoietic cells (Fig. 1). There was
no evidence of leukemia, dysplasia, or an inﬁltrative process noted
in the marrow sample. Serum Epstein-Barr virus and cytomegalo-
virus immunoglobulin M titers were undetectable. Acid-fast
bacterial smear was negative. A chronic hepatitis panel showed
immunization with hepatitis B surface antibody. A few days later,
both bone marrow bacterial culture and central venous catheter tip
culture isolated Serratia marcescens, and the in vitro susceptibility
testing was identical. Antibiotics treatment with meropenem
1000 mg every 12 hours was started by microbiologic report and
lasted for 14 days, and was then deescalated to cefpirome 1000 mg
every 12 hours for the following 28 days. The pancytopenia grad-
ually improved after 3 weeks of antibiotics treatment. After her
serum glucose level was well controlled and steady hemodialysis of
uremia had occurred, the patient was discharged from the hospital.
The hemoglobin level and platelet counts were within normal
range during monthly outpatient follow-up.
3. Discussion
The pattern of disease leading to pancytopenia by bone marrow
failure may vary in different population groups with their differ-
ences in age pattern, nutritional status, and the prevalence ofFig. 1. Bone marrow biopsy section revealed decreased hematopoiesis with hypo-
cellularity (magniﬁcation 20).infection. Two prospective studies identiﬁed the causes of pancy-
topenia and bone marrowmorphology, and both revealed the most
common cause was aplastic anemia, followed by megaloblastic
anemia, hematologic malignancy, and hypersplenism1,11.
Aplastic anemia is an uncommon disease that is caused by
immune-mediated T-lymphocyte destruction of hematopoietic
stem cells leading to peripheral pancytopenia and symptoms of
bone marrow failure, which is a feature of many serious and life-
threatening diseases3. The cause of aplastic anemia is unknown
in approximately one-ﬁfth of cases. Other possible causes can be
inherited bone marrow syndrome, clonal disorders, or much more
often, acquired disorders. The major causes of acquired aplastic
anemia are exposure to a wide variety of drugs and chemicals,
ionizing radiation, and some viruses3,6.
The diagnosis of aplastic anemia is suggested by the complete
blood count and bone marrow examination. The complete blood
count reveals pancytopenia along with a reduction of absolute
reticulocytes, normocytic, or macrocytic red blood cells, and no
abnormal cells such as myeloblasts or atypical lymphoid cells. The
typical bone marrow would be hypocellular with decreased
elements, marrow space composed of mostly fat and stroma and
absent of malignant cells or ﬁbrosis inﬁltration, and normal
morphologically of residual hematopoietic cells2. Once the diag-
nosis of aplastic anemia has been made, laboratory workup should
include screening for infections, such as hepatitis B and C, Epstein-
Barr virus, cytomegalovirus, human immunodeﬁciency virus,
parvovirus, and Mycobacteria species; prolonged medication
exposure; environmental exposure; underlying bone marrow
failure disorder such as Fanconi anemia, amegakaryocytic throm-
bocytopenia, or paroxysmal nocturnal hemoglobinuria7.
In this case, after pancytopenia developed, the morphology of
bone marrow revealed marked hypocellularity with few hemato-
poietic cells, consistent with an aplastic marrow. We excluded
common chemical, viral, immunologic, or congenital causes of
aplastic anemia. Severe sepsis in elderly patients may cause
signiﬁcant hematologic and biochemical abnormalities including
decreased hemoglobin level, decreased platelet counts, and
elevated leukocyte counts12, which are important clinical concerns
but not in accordance with our ﬁndings. By further survey, both
bone marrow and central venous catheter tip cultures isolated
Serratia marcescens after complete treatment of previous bacterial
pathogens.
It could be argued that the acquired aplastic anemia was caused
by the infection, the drugs, the antibiotics, or all of these factors.
The most strongly associated drugs were penicillamine, gold, and
carbamazepine, and the relative risk point estimates for anti-
infective agents were elevated for trimethoprim/sulfonamides,
macrolides, and b-lactams4,5. None of these drugs had been used
before aplastic anemia developed, except imipenem for a short
period.
Bone marrow bacterial infection as a cause of acquired aplastic
anemia is a rare condition reported before. S. marcescens is a well-
recognized nosocomial pathogen predominantly transmitted
through patient-to-patient contact and also associatedwith various
medical and surgical procedures. Infections vary from outbreaks in
small groups of patients to outbreaks inwhole wards or even entire
hospitals. The outbreak could be controlled by patient isolation and
intensiﬁed hand washing10. There is also evidence that environ-
mental hygiene, such as hydrogen peroxide vapor, is important for
the eradication of environmental S. marcescens. The treatment of
nosocomial S. marcescens infection remains antibiotics therapy
and removal of the infectious source if possible. According to
a retrospective study at a medical center in Taiwan, approximately
15% of S. marcescens infections produced extended-spectrum
b-lactamases. Attention should be devoted to the detection of
H.-W. Wang et al.224extended-spectrum b-lactamases-producing S. marcescens to avoid
potential treatment failure9.
In summary, this case represents a rare but potentially fatal
incidence of aplastic anemia from nosocomial S. marcescens bone
marrow infection. In addition, our patient was not on any other
medications that could have caused marrow aplasia. As nosocomial
resistant pathogens become more wide spread in the elderly, bone
marrow study including bacterial cultures should be executed
when pancytopenia develops unexpectedly in an elderly patient
without preexisting underlying conditions. The mortality and
morbidity rate can be high if an early diagnosis cannot be
established.References
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